Tralokinumab: Discovering the Potential of LP 0162 and CAT-354 Tralokinumab, previously known as LP 0162 and CAT-354, represents a promising therapy for chronic dermatitis. This humanized antibody blocks https://aoifepnpf868744.wikiannouncing.com/user